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The adipokine leptin regulates energy balance, appetite, and reproductive maturation. 
Leptin also acts on bone growth and remodeling, but both osteogenic and anti-osteo-
genic effects have been reported depending on experimental conditions. Siberian ham-
sters (Phodopus sungorus) have natural variation in circulating leptin concentrations, 
where serum leptin is significantly decreased during the short day (SD)-induced winter 
state. In summer long day (LD) photoperiods, appetite and body adiposity increase 
with associated central leptin insensitivity. This natural change in leptin secretion was 
exploited to investigate leptin’s effect on bone growth. Hamsters were injected with 
calcium-chelating fluorescent dyes to measure bone mineral apposition rate (MAR). 
Measurements were initially obtained from 5-week and 6-month-old animals maintained 
in low leptin (SD) or high leptin (LD) states. A further study investigated effects of chronic 
administration of recombinant mouse leptin to hamsters housed in SD and LD condi-
tions; growth plate thickness and bone density were also assessed. As expected, a 
reduction in body mass was seen in hamsters exposed to SD, confirming the pheno-
type change in all studies. Serum leptin concentrations were significantly reduced in SD 
animals in all studies. MAR was reproducibly and significantly increased in the femurs 
of SD animals in all studies. Vitamin D and growth plate thickness were significantly 
increased in SD animals at 6 months. No effect on bone density was observed in any 
study. Taken together these data suggest that bone growth is associated with the low 
leptin, winter, lean state. In leptin-treated animals, there was a significant interaction 
effect of leptin and photoperiod. In comparison to their vehicle counterparts, SD animals 
had decreased and LD animals had increased MAR, which was not apparent prior to 
leptin administration. In conclusion, increased MAR was associated with low serum 
leptin levels in early life and sustained over 6 months, implying that leptin has a negative 
effect on bone growth in this model. The unexpected finding that MAR increased after 
peripheral leptin administration in LD suggests that leptin exerts different effects on bone 
growth dependent on initial leptin status. This adds further weight to the hypothesis that 
leptin-treated LD animals display central leptin resistance.
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inTrODUcTiOn
Leptin is a 16-kDa peptide hormone which is synthesized and 
released primarily by adipose tissue (1). Circulating concentra-
tions are positively correlated with increases in peripheral 
body fat (2). Leptin was first investigated for its role in appetite 
regulation and control of energy expenditure (3), but since then 
it has been discovered that leptin and its receptor are involved 
in regulation of reproduction, immune function, serum glucose 
levels, angiogenesis (4), and bone homeostasis (5).
A number of animal models have been used to understand the 
role of leptin in bone mass accrual, including the ob/ob mouse 
which cannot produce leptin and the db/db mouse which has 
dysfunctional leptin receptors. Initial studies by Ducy et al. (5) 
found ob/ob mice to have a high bone mass phenotype in their 
vertebrae and femurs and an increased bone formation rate 
compared to wild-type animals. In contrast, Steppan et  al. (6) 
found that a high bone mass in the long bones of ob/ob mice was 
achieved only after administering peripheral leptin. Hamrick 
et  al. (7) showed that contrasting bone phenotypes could also 
appear within the same ob/ob model, with lumbar vertebrae 
being longer and having an improved bone architecture, whereas 
femurs were shorter with poor bone architecture.
In the current literature, four mutations in the gene coding 
for leptin have been reported which lead to leptin deficiency 
and result in severe obesity (8–12). Leptin replacement has been 
investigated as a potential treatment to be used in cases of leptin 
deficiency (13), and so it is important to understand the effects of 
leptin on bone. However, leptin deficiency is rare, and it is more 
common to find extremely low or high levels in humans rather 
than a complete lack. Lipodystrophy, for example, is characterized 
by the loss of subcutaneous adipose tissue (14), which results in 
low circulating leptin levels and has been associated with human 
immunodeficiency virus antiviral treatments (15). Low leptin 
levels are also found in those suffering from anorexia nervosa 
and hypothalamic amenorrhea, and conversely, high circulating 
leptin levels are found in obesity.
The Siberian hamster, Phodopus sungorus, has been used 
extensively as a robust model of seasonal change which has been 
used to investigate energy expenditure, reproductive changes, 
and adiposity (16, 17). The Siberian hamster seasonal change 
is stimulated by changes in the production of melatonin, which 
increases during the short day (SD; winter) photoperiod and 
prompts metabolic and physical changes (18). Upon exposure 
to SD photoperiods, they reduce their food intake, even if given 
food ad libitum (19), which reduces their body weight, abdominal 
fat reserves, and serum leptin levels. In addition, reproductive 
system regression occurs in both sexes; the testes and epididymal 
fat pad weights of males and uterine weight of females are mark-
edly reduced in SD-exposed animals (20), resulting in decreased 
levels of circulating sex hormones (21, 22). Conversely, exposure 
to long day (LD; summer) photoperiods increases appetite and 
results in lipogenesis, increased body mass, larger reproductive 
organs, and elevated leptin production. This comprehensive 
response to photoperiod provides a model to investigate bone 
growth and remodeling in animals with naturally high and low 
serum leptin levels.
Only one previous study has examined bone parameters in 
the Siberian hamster model and found no evidence for effects 
of recombinant leptin on trabecular bone mass or mechanical 
properties of bone; however, this study did not measure bone 
growth (23). The aim of this study was to use the naturally high 
and low leptin levels, induced by photoperiod in the Siberian 
hamster, as a model system to investigate the relationship 
between circulating leptin concentrations and bone mineral 
apposition rate (MAR) and bone density. Following from this, 
the mechanistic effect of leptin on any observed changes was 
investigated by supplementing animals in both photoperiodic 
states with peripheral leptin and measuring MAR longitudinally 
before and after leptin supplementation.
MaTerials anD MeThODs
animals
All studies were carried out in accordance with the UK Animals 
(Scientific Procedures) Act of 1986 (project licenses: PPL 40/3065 
and PPL 40/3604) and approved by the University of Nottingham 
Animal Welfare and Ethical Review Board. Animals were from 
a colony of Siberian hamsters (P. sungorus) maintained at the 
University of Nottingham Biomedical Services Unit (20). Animals 
were group housed in 21°C and 40% humidity conditions and 
allowed ad libitum access to water and food (Teklad 2019 global 
19% protein extruded rodent diet, Harlan, UK). Hamsters were 
housed in either LD conditions comprising 16 h light:8 h dark or 
SD conditions of 8 h light:16 h dark.
experimental Procedure—study 1
Siberian hamsters (three females and one male) from mothers 
that were either housed in LD throughout or from mothers that 
had been exposed to SD as soon as pregnancy was detected by 
palpation, generally about 7 days before parturition (four females 
and two males) were studied (Figure 1). At 3 weeks, the animals 
were injected with 150  mg/kg of alizarin (Sigma, UK), and 
10 days later they were injected with 100 mg/kg of calcein (Sigma, 
UK). Both dyes were diluted in 1.4% sodium bicarbonate and 
injected into the intraperitoneal cavity. A week later, the animals 
were euthanized with sodium pentobarbital (Euthatal, Merial, 
UK). Fore and hind limb long bones and lumbar vertebrae were 
removed for cortical appositional growth analysis, and serum was 
obtained for analysis of vitamin D and leptin levels.
experimental Procedure—study 2
Male Siberian hamsters were randomly housed in LD (n =  6) 
or SD (n =  7) conditions from the age of 12 weeks and left to 
acclimatize for 5  weeks. At 17  weeks of age, all animals were 
injected with 75  mg/kg of alizarin, and this was repeated at 
18.5  weeks (Figure  1). At 20  weeks, the animals were injected 
with 40 mg/kg of calcein, which was repeated at 21.5 weeks. Both 
dyes were diluted in 1.4% sodium bicarbonate and injected into 
the intraperitoneal cavity. Both dyes were administered at lower 
concentrations than study 1 to prevent potential distress to the 
animal by administering the larger volumes needed for the larger 
animal size. The animals were euthanized at 24  weeks using 
FigUre 1 | Experimental protocol schemes for studies 1, 2, and 3. Timelines showing the stages of each study, including birth, transfer into the photoperiod 
environments, the timings of calcein and alizarin injections, and the end of study.
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sodium pentobarbital (Euthatal, Merial, UK). The testes and 
testicular fat pads were removed from each animal and weighed. 
Lumbar vertebrae and femurs were removed for cortical appo-
sitional growth analysis, and serum was obtained for analysis of 
vitamin D and leptin levels.
experimental Procedure—study 3
Female Siberian hamsters were randomly housed in LD or SD 
conditions from the age of 14 weeks and left to acclimatize for 
5  weeks (n =  12 per photoperiod) (Figure  1). At 19.5  weeks, 
all animals were injected with 30  mg/kg of alizarin, and this 
was repeated at 21 weeks. 3 days later, each animal received an 
osmotic mini-pump containing either vehicle or leptin (n = 12 
per treatment split evenly per photoperiod). Animals were 
randomly assigned pumps although it was ensured that each 
cage housed at least one animal with vehicle treatment and one 
animal with leptin. At 24 weeks, the animals were injected with 
20 mg/kg of calcein, which was repeated at 25.5 weeks. Both dyes 
were diluted in 0.01 M PBS and injected subcutaneously. Both 
dyes were administered at lower concentrations than study 2 
to prevent potential distress to the animal by administering the 
larger volumes needed for the larger animal size. The animals 
were euthanized 3 days after the second calcein injection using 
sodium pentobarbital (Euthatal, Merial, UK). The ovaries and 
fallopian tubes and the retroperitoneal fat pads were removed 
from each animal and weighed. Femurs were removed for corti-
cal appositional growth analysis, growth plate histology, and 
microCT analysis. Serum samples were obtained for analysis of 
leptin and bone markers.
administration of leptin
Alzet osmotic mini-pumps (2004 model, Charles River, UK) were 
used to deliver recombinant mouse leptin (R&D Systems, UK) 
diluted in 20 mM Tris/HCl (pH 8). Animals were anesthetized 
under isoflurane (2–3%), and the mini-pumps were inserted 
subcutaneously in the flank region. Each mini-pump delivered 
15 μg/day leptin over a 28-day period, a concentration previously 
shown to increase the serum leptin levels of Siberian hamsters 
after 14 days of continuous treatment (23–25).
Blood serum analysis
Blood samples were acquired via cardiac puncture, and the 
plasma supernatant was collected and stored at −80°C. Serum 
leptin concentration was measured using a commercial “sand-
wich” ELISA (Mouse Leptin ELISA kit; Millipore, USA). The 
resulting absorbance was read at 450 and 590 nm using a mul-
tiskan spectrum spectrophotometer (Thermo Scientific, USA). 
The difference between the two readings was interpolated from 
a curve of the known leptin standards. The quality controls were 
also interpolated from the curve and fell within the acceptable 
range.
25-Hydroxy vitamin D3 analysis by mass spectrometry was 
kindly undertaken at the Department of Clinical Biochemistry 
at Norfolk and Norwich University Hospital using a Micromass 
Quattro Ultima with Masslynx acquisition software (Waters, 
USA) and their standard operating procedure.
Blood serum was analyzed for levels of interleukin-6 (IL-6), 
adrenocorticotropic hormone (ACTH), insulin, receptor activa-
tor of nuclear factor kappa-B ligand (RANKL), leptin, and tumor 
FigUre 2 | Representative microCT images as reconstructed by the Scanco 
software. (a) A whole femur. (B) Transverse sections through the femur from 
the distal (knee) end, showing trabecular structure. (c) Longitudinal sections 
through the femur at the distal (knee) end, showing trabecular structure and 
the growth plate.
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necrosis factor α (TNFα). This was completed using a Milliplex 
map mouse bone panel 2A (Millipore, USA) assay kit. The plate 
was read using a MAGPIX analyzer (Luminex, USA), and sample 
values were interpolated from known standards using the built-
in xPONENT software.
appositional growth
Bone samples, including femora and vertebrae, were fixed in 4% 
paraformaldehyde and embedded in JB4 resin (Agar Scientific, 
UK) for sectioning. Samples were dehydrated through increasing 
grades of ethanol (50, 70, and 90%), being in each concentration 
for 24 h. They were transferred to infiltrating resin and placed 
on a rocker for 48 h, with three changes of the resin during this 
time period. The samples were orientated in plastic molds and 
covered in embedding resin, which was polymerized in an anaer-
obic environment using anaerocult bags and sachets (Merck, 
UK) at 4°C overnight. The samples were sectioned at 10 µm onto 
gelatin-coated slides using a Leica supercut 2050 microtome.
Sections were imaged using a Leica DMRB fluorescence 
microscope with a Hamamatsu C4742-95 camera and Openlab 
(Perkin Elmer, USA) acquisition software. Images were acquired 
where bands of alizarin (red) and calcein (green) were observed 
next to each other in the cortical bone of the shaft of the long 
bones and the vertebral body of the lumbar vertebrae. Images 
were analyzed by measuring the distance between the bands 
using ImageJ software (National Institutes of Health, USA). 
A grid of crosses (1.17 cm2 per point) was laid over the image and 
where a grid point met one of the fluorescent bands, the distance 
measured was from that point to the nearest point on the next 
band. A minimum of 10 measurements were recorded for each 
bone, and the final value was an average of these measurements.
growth Plate
One femur from each animal was fixed in 4% paraformaldehyde 
for 48 h, decalcified in 10% EDTA in 0.1 M Tris (pH 7.4), and 
snap-frozen in isopentane (supercooled in liquid nitrogen). The 
samples were sectioned on a Leica CM1850 cryostat at 10 µm onto 
gelatin coated slides and were stained with Harris hematoxylin 
and 1% eosin (EMS, USA). The sections were imaged using a Leica 
DM4000B light microscope using a QImaging MicroPublisher 
RTV 3.3 camera and Openlab (Perkin Elmer, USA) acquisition 
software. The widths of proliferative and hypertrophic zones 
in clearly defined columns of the growth plate were measured 
using ImageJ software (National Institutes of Health, USA). 4–6 
measurements were recorded per zone for each animal.
MicrocT
MicroCT was carried out using one femur from each animal, 
which were embedded in resin as described above. Samples were 
scanned using a Scanco μCT40 (beam energy: 55 kVp, beam 
intensity: 145 µA, 200 ms integration time, and spatial resolution: 
10 µm). Image reconstruction and analysis were performed using 
Scanco software (Figure 2).
statistics
Sample sizes were selected for studies 1 and 2 such that these 
experiments were sufficiently powered to detect a significant 
effect of photoperiodic treatment on body weight at 5  weeks 
and 6 months of age, respectively. For study 3, group sizes were 
the same as those previously used by Atcha et al. (25) who dem-
onstrated that leptin infusions (15 μg/day) caused a significant 
reduction in adiposity in Siberian hamsters maintained in short 
days.
Data were analyzed by linear regression, unpaired t-test, one-
way ANOVA and two-way ANOVA with Tukey’s post  hoc test 
using Prism software (GraphPad, USA). Data are presented as 
mean ± SD.
resUlTs
study 1—The effect of Photoperiod  
on the Mar of Juvenile (5-Week Olds) 
siberian hamsters
Siberian hamsters were housed in either LD or SD photoperiods 
from confirmation of pregnancy. Those born and housed post-
natally in SD were significantly lighter than those in LD at all 
points until the termination of the study at day 39 (P < 0.0001, 
Figure 3A). Animals housed in SD had significantly decreased 
blood serum leptin levels compared to LD (P  =  0.0124, 
Figure  3B), and leptin levels were positively correlated with 
body weight within the whole cohort (r2 = 0.6283, P = 0.0108; 
Figure  3C). There was no difference in blood serum levels of 
vitamin D3 between the photoperiod groups at the end of the 
study (Figure 3B).
The hamsters were injected with calcium chelating dyes to 
label the mineralizing front in the cortical bone of their skeletons 
(Figure 4A). The distance between the labels was measured as 
growth over time and known as the MAR. Bone samples from 
both the axial and appendicular skeleton were analyzed. A pho-
toperiodic difference was observed in the hind limb bones (femur 
and tibia), which showed an increased MAR in SD animals 
compared to LD animals (P = 0.0045, Figure 4C). There was no 
FigUre 3 | Physiological measurements of juvenile (5-week olds)  
Siberian hamsters born and weaned in long day (LD) and short day (SD) 
photoperiods. (a) Animal body weights recorded from 21 to 39 days old.  
(B) Serum levels of leptin and 25(OH)D3 from blood collected at 39 days old. 
Data are mean ± SD for n = 4 LD and n = 5 SD animals. ****P < 0.0001, 
two-way ANOVA; *P < 0.05, unpaired t-test. (c) Correlation between body 
weight and serum leptin level (n = 9, LD and SD animals combined), linear 
regression applied to data from individual animals.
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difference seen in the MAR of the lumbar vertebrae (Figure 4B) 
or the fore limb bones (Figure 4D).
study 2—The effect of Photoperiod  
on the Mar of adult (6-Month Olds) 
siberian hamsters
To investigate MAR in older Siberian hamsters over a longer 
time period, male hamsters gestated and raised in LD were 
placed in either LD or SD environments at 12 weeks of age and 
monitored for a further 12 weeks. SD-housed Siberian hamsters 
had significantly decreased body weights compared to those in 
LD (P < 0.0001, Figure 5A) and had significantly reduced food 
intake over the course of the study (P =  0.0014, Figure  5B). 
The animals housed in SD showed reproductive regression and 
reduced adiposity, as measured by the wet weights of testes and 
fat pads, respectively (P < 0.0001, Figure 5C). Blood serum leptin 
levels were reduced in the SD animals (P = 0.0001, Figure 5D), 
and leptin levels were positively correlated with body weight 
within the whole cohort (r2 = 0.7446, P = 0.0001, Figure 5E). 
Blood serum 25(OH) D3 levels were increased in SD animals 
(P <  0.05, Figure  5D), and these levels were negatively cor-
related with body weight within the whole cohort (r2 = 0.6964, 
P = 0.0007, Figure 5F).
Based on results from the first study, MAR was measured 
in the cortical bone of the femurs and the lumbar vertebrae. 
Calcium chelating dyes were injected at four time points to 
give three measurements of growth over time (Figure  6A). 
SD-housed hamsters had a significant increase in femoral MAR 
compared to LD animals (P = 0.0106, Figure 6B), but there was 
no difference in vertebral MAR between the two groups at any 
time point (Figure 6C).
study 3—The effect of leptin Treatment 
on the Mar, growth Plate size, and Bone 
architecture of adult siberian hamsters
Study 3 was designed to investigate whether the low blood 
serum leptin levels observed in SD-housed hamsters contrib-
uted to the increased femoral cortical MAR observed in study 
2. Animals raised in LD were transferred to SD photoperiods 
at 14 weeks of age or remained in LD, and at 22 weeks of age 
were treated with vehicle or leptin for 28 days via an osmotic 
mini-pump. Hamsters were treated with 15 μg/day leptin, a dose 
that had previously been shown to increase the blood serum 
leptin concentration of SD animals to levels comparable with 
LD animals (23, 24). Animals housed in the SD photoperiod had 
decreased body weights compared to those in LD (P < 0.0001, 
Figure 7A). There was no significant effect of leptin treatment 
on body weight in hamsters in either photoperiod (Figure 7A). 
SD-housed hamsters had decreased food intake over time com-
pared to LD animals (P =  0.0003, Figure  7B). To avoid cage 
bias, animals from both treatment groups were housed together 
in the same photoperiod cage. Therefore, food intake data could 
only be compared for the photoperiod groups and not individual 
treatment groups.
Animals housed in the SD photoperiod had significant 
regression of their reproductive systems as assessed by the wet 
weight of ovaries and uteri and less retroperitoneal fat than 
those housed in LD (P = 0.0006, Figures 7C,H and P < 0.0001, 
Figures  7D,H respectively). There was no significant effect of 
leptin treatment on these parameters in either photoperiod.
Siberian hamsters housed in SD conditions had decreased 
blood serum levels of leptin (P = 0.0017, Figures 7E,H) and insulin 
(P = 0.0035, Figures 7F,H). There was a significant interaction of 
photoperiod and leptin on insulin levels (P = 0.0206, Figure 7H); 
FigUre 4 | Effect of photoperiod on the mineral apposition rate (MAR) of lumbar vertebrae and long bones of juvenile (5-week olds) Siberian hamsters.  
(a) Representative double-labeled image showing the alizarin and calcein incorporation into the cortical bone of the femur, with an experimental schematic.  
Scale bar = 100 µm. (B) MAR of lumbar vertebrae, (c) hind limb long bones, and (D) fore limb long bones measured over 10 days (21–31 days old). Data are 
mean ± SD from n = 4 LD and n = 5 SD animals. **P < 0.01, unpaired t-test.
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post hoc tests revealed that insulin levels were decreased in the 
leptin-treated animals in LD but not in SD (P < 0.05, Figure 7F). 
An overall effect of photoperiod on serum RANKL levels indi-
cated that levels were higher in hamsters in SD; leptin treatment 
did not affect this (Figures  7G,H). There was no difference in 
the ACTH levels of any photoperiod or treatment group, and the 
bone panel assay did not detect the presence of IL-6 and TNFα in 
the blood serum samples (data not shown).
Calcium chelating dyes were injected to assess femoral cortical 
MAR both before and during the treatment period (Figure 8A). 
Before treatment, there was no significant effect of photoperiod 
on MAR in femurs (Figures 8B,E). During the first period of 
treatment (21–24 weeks of age) there was a significant interac-
tion of leptin and photoperiod (P = 0.0354, Figures 8C,E), but 
no main effect of the variables individually. During the second 
period of treatment (24–25.5 weeks), the animals housed in the 
LD photoperiod had a decreased femoral MAR compared to SD 
hamsters (P = 0.0309). There was a very significant interaction 
of leptin and photoperiod (P = 0.0067, Figures 8D,E), thus MAR 
was increased in leptin-treated hamsters in LD, but reduced in 
those in SD (Figure 8E).
Femoral growth plates were labeled with hematoxylin and 
eosin in decalcified frozen sections. The proliferative and hyper-
trophic zone widths of a column were measured and recorded 
individually along with the total width of the two zones com-
bined (Figure 9A). Overall, the growth plates of the SD housed 
hamsters were wider than those housed in LD, with a significant 
increase being observed in the total growth plate (P <  0.0001, 
Figures 9B,E). This significant effect of photoperiod was evident 
when the proliferative (P =  0.0001, Figures  9C,E) and hyper-
trophic zones (P = 0.001, Figures 9D,E) were analyzed separately. 
There was no effect of leptin treatment on the width of any of the 
zones measured.
MicroCT analysis of the femurs was carried out to detect 
cortical and trabecular bone differences within the treatment 
groups. There was a significant increase in bone volume of the SD 
hamsters’ tibias compared to the LD housed animals (P = 0.02), 
but no significant effect of leptin treatment. There were no differ-
ences in the other parameters measured, including bone surface, 
density and number, spacing and thickness of the trabeculae 
(Table 1).
DiscUssiOn
Our data demonstrate a significant effect of photoperiod on 
indicators of bone growth in Siberian hamsters. This study 
investigated appositional bone growth, via MAR, and measured 
longitudinal bone growth at the cartilage growth plate and found 
both to be increased in SD housed animals. We further investi-
gated leptin as a potential mediator of this effect and found it to 
have an anti-osteogenic effect on MAR but no effect on growth 
plate width.
The Siberian hamster model is well established as a means 
of examining the effects of photoperiod on energy balance. 
FigUre 5 | Physiological measurements of adult (6-month olds) male Siberian hamsters housed in long day (LD) and short day (SD) photoperiods. (a) Body weight 
recorded at least every 2 weeks from 12 to 24 weeks old. (B) Food intake displayed as a cumulative average per cage (n = 2 LD and n = 3 SD cages, 2–4 animals 
per cage). (c) Paired testes and epididymal fat pads were removed at 24 weeks old and weighed. (D) Serum leptin and 25(OH)D3 levels were measured in blood 
taken at 24 weeks old. Data are mean ± SD of n = 6 LD and n = 7 SD, unless otherwise stated. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, (a,B) two-way 
ANOVA; (c,D) unpaired t-test. (e) Correlation between 24-week-old body weight and serum leptin level and (F) correlation between 24-week-old body weight and 
serum vitamin D3. Linear regression applied to data from individual animals.
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We found that SD animals had decreased food intake, body 
weight, and associated decreases in body fat, despite being fed 
ad libitum, consistent with many reports in the literature [see 
Ref. (16, 17) for review]. In addition, both male and female SD 
animals underwent reproductive system regression, and we 
observed seasonal changes in pelage. Importantly, we found 
SD animals to have significantly lower serum leptin levels than 
their LD counterparts. Further serum analysis showed a signifi-
cantly increased serum vitamin D level in the SD state, which 
considering their reduced food intake and light exposure might 
not have been predicted. This may be due, however, to the fat-
soluble nature of vitamin D which may have been sequestered 
in adipose tissue and released as abdominal fat reserves are 
catabolized in SD (26, 27).
The seasonal change in leptin observed in rodent models 
has rarely been investigated in relation to its effect on bone; the 
single study in this area found no effect of a 1 week leptin sup-
plementation on bone mass or mechanical properties, but did 
not investigate bone growth (23). The present study investigated 
appositional bone growth via MAR and measured longitudinal 
bone growth at the cartilage growth plate in addition to bone 
density studies. We have shown a significant and consistent 
increase in MAR of SD animals independent of gender and age 
in the cortical bone of the hind limbs (tibias and femora). This 
study allowed us for the first time to also analyze chondrocyte 
responses to photoperiod in the growth plates. We investigated 
growth plate size in 6-month-old female animals and found a 
significant increase in total growth plate width in the SD state 
and specific increases in the proliferative and hypertrophic zones 
of animals. An initial study of bone mass at 5 weeks of age and 
a more comprehensive study of tibial bone mass parameters 
at 6  months of age showed no significant difference (data not 
shown). An increase in total bone volume in SD hamsters was 
observed; however, this is more attributed to an increase in bone 
growth than bone density. These bone density data are consistent 
with the previous study (23) that used the same animal model at 
FigUre 6 | Effect of photoperiod on the mineral apposition rate (MAR) of femurs and lumbar vertebrae of adult (6-month olds) male Siberian hamsters.  
(a) Representative labeled image showing the double alizarin and double calcein incorporation into the cortical bone of the femur, with an experimental schematic. 
Scale bar = 100 µm. (B) MAR of femurs and (c) lumbar vertebrae measured at three intervals over 4.5 weeks. Data are mean ± SD, n = 6. *P < 0.05, two-way 
ANOVA.
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similar ages and leptin dose levels, but with a shorter duration 
of leptin supplementation: the present study treated hamsters 
for 4 weeks beginning at 22 weeks of age compared to 2 weeks 
beginning at 24  weeks of age. We have added significantly to 
the findings of Rousseau et  al  (23) by showing a reproducible 
negative effect of the LD higher leptin state on parameters of 
bone growth.
Although our results suggest decreased levels of serum leptin 
are beneficial to bone growth, other factors that could potentially 
affect bone growth also differ between the photoperiod states. 
In the SD state, Siberian hamsters undergo regression of the 
reproductive system, and as would be expected this is associated 
with a decrease in circulating levels of estradiol in female ham-
sters (21). Additionally, in male hamsters, testosterone levels 
are decreased in SD-housed animals (22), meaning there is less 
available for aromatization to estradiol. The decrease in circulat-
ing estrogens in women after menopause is strongly linked to the 
higher bone turnover rate and subsequent bone loss observed 
in post-menopausal osteoporosis, with estradiol treatment 
reversing the phenotype in ovariectomized animals. As such, it 
would be expected that the lower sex hormone levels would have 
a negative effect on the bone metabolism of SD-housed animals 
and that this would be observed in their bone density measure-
ments. As this was not the case for either sex, it is unlikely that 
this factor contributed to the changes in bone growth rate seen 
in the SD state.
The nocturnal duration of pineal melatonin secretion 
increases in SD-housed Siberian hamsters (28), and this prompts 
the development of the SD phenotype through actions in the 
pars tuberalis and hypothalamus (18). Melatonin has been sug-
gested to have a positive direct effect on bone growth, although 
the mechanism has not been clearly established. Satomura 
et  al. (29) observed an increase in murine femoral MAR after 
treatment with melatonin, but in contrast, Koyama et  al. (30) 
found that although melatonin had positive effects on bone 
density in mice, it had no effect on MAR. The differences seen 
were hypothesized to be due to a decrease in resorption rather 
than an increase in bone formation, despite other groups finding 
melatonin increases human osteoblast proliferation and produc-
tion of differentiation markers in  vitro (29, 31). The currently 
published literature demonstrates that melatonin has an impact 
on MAR, and therefore, could be a factor contributing to the 
increased cortical MAR observed in this study. Unfortunately, no 
direct comparison can be made, due to the melatonin treatment 
in these studies being at a supraphysiological level.
25-Hydroxy vitamin D3 levels differed between the photo-
period groups and were increased in SD animals where body fat 
was reduced, but the impact of increased vitamin D is reported 
as both positive and negative. For example, human studies have 
shown vitamin D3 supplementation to have a positive effect on 
bone mineral density in adult girls (32), and serum levels to be 
positively correlated with bone mineral density of young and 
old people (33). In contrast, in  vitro studies with human and 
animal bone cells have shown vitamin D3 to have negative effects 
on cell proliferation and differentiation (34, 35). In addition, 
murine osteoblasts lacking the vitamin D receptor had increased 
proliferation and increased early and late differentiation markers 
mineralization (36). These contrasting findings may be due to the 
FigUre 7 | Physiological measurements of adult (6-month olds) female Siberian hamsters housed in long day (LD) and short day (SD) photoperiods and treated 
with vehicle (20 mM Tris/HCl) or leptin (15 μg/day). (a) Body weight recorded every 2 weeks from 14 to 26 weeks old. (B) Food intake displayed as a cumulative 
average per cage (n = 6 cages, 1–3 animals per cage). (c) Reproductive system (ovaries and fallopian tubes) and (D) retroperitoneal fat pads were removed at 
26 weeks old and weighed. (e) Serum leptin, (F) insulin, and (g) RANKL levels were measured in blood taken at 26 weeks old. Data are mean ± SD, n = 6 (n = 5, 
long day—vehicle). *P < 0.05, ***P < 0.001, and ****P < 0.0001, (a,B) two-way ANOVA; (c–g) two-way ANOVA with Tukey’s post hoc test, with statistical data 
shown in (h), NS—not significant. Box represents the period of vehicle/leptin treatment.
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role of vitamin D in both increasing bone resorption to release 
calcium reserves from bone and encouraging bone formation 
at times of excess calcium availability. As vitamin D levels were 
increased in the present study in the SD phenotype, vitamin D 
could have contributed to the increased MAR seen; however, its 
effect remains unknown.
Given that factors other than leptin have potentially influ-
enced the increased MAR seen in SD animals, a second set of 
studies was carried out to understand better the potential role of 
leptin. Siberian hamsters exposed to SD were treated peripher-
ally with murine leptin at a dose level designed to restore LD 
concentrations of leptin. Previous studies showed that peripheral 
treatment of 15 μg/day leptin over 2 weeks increased the serum 
leptin levels of a SD animal to that of a hamster housed in the 
LD environment (23–25). A strength of the present study was 
the ability to monitor MAR changes longitudinally, and it was 
FigUre 8 | Effect of photoperiod and vehicle (20 mM Tris/HCl) or leptin (15μg/day) treatment on the femoral mineral apposition rate (MAR) of adult (6-month olds) 
female Siberian hamsters. (a) Representative labeled image showing the double alizarin and double calcein incorporation into the cortical bone of the femur, with an 
experimental schematic showing the point at which vehicle or leptin treatment began. Scale bar = 100 µm. MAR of femurs measured at (B) 19.5–21 weeks—before 
treatment, (c) 21–24 weeks—during treatment, and (D) 24–25.5 weeks—during treatment. Data are mean ± SD, n = 6 (n = 5, LD—vehicle). **P < 0.01, two-way 
ANOVA with Tukey’s post hoc test, with statistical data shown in (e), NS—not significant.
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therefore designed to measure MAR before treatment started and 
again after 2 weeks of treatment, at which point the leptin levels 
of the SD treated and LD vehicle animals would be expected to 
be similar.
The same robust effect of SD photoperiod on body weight, 
food intake, reproductive regression, fat weight, and serum leptin 
levels was observed. However, there was no difference in any of 
these parameters when comparing the vehicle and leptin-treated 
animals in either photoperiod. Food intake was only compared 
between photoperiods, as hamsters from different treatment 
groups were housed together. This is a potential limitation of 
the study; however, it was deemed that removing the potential 
bias of housing the treatment groups separately outweighed the 
gain of information from the food intake. In addition, it has 
been previously demonstrated that the change in body weight 
observed in leptin-treated Siberian hamsters can occur without 
a significant change in food intake (25). The failure to observe a 
metabolic response in LD animals has been observed in previ-
ous studies using this dose of leptin and is potentially due to 
a development of central resistance (23–25). Levels of bone 
markers had not previously been reported in these animals, and 
this study found that RANKL was increased in SD animals. This 
would imply an increase in osteoclastogenesis and therefore 
bone resorption; however, there were no observed differences 
in bone density and architecture. This is difficult to interpret in 
isolation, and investigation into the RANKL/OPG ratio would 
shed further light on the relevance of this finding. Insulin levels 
were decreased in the SD animals in agreement with Bartness 
et al. (37), and additionally, an interaction effect of leptin and 
photoperiod was observed. Leptin has been shown to decrease 
glucose-stimulated insulin secretion in a dose-dependent man-
ner through central, rather than peripheral mechanisms (38). 
FigUre 9 | Effect of photoperiod and vehicle (20 mM Tris/HCl) or leptin (15 μg/day) treatment on the femoral growth plate width of adult (6-month olds) female 
Siberian hamsters. (a) Representative decalcified, H&E-stained growth plate showing measurement of proliferative and hypertrophic zones, scale bar = 100 µm.  
(B) Total growth plate, (c) proliferative zone, and (D) hypertrophic zone widths, measured where clearly defined columns were visible. Data are mean ± SD, n = 5. 
Two-way ANOVA with Tukey’s post hoc test, with statistical data shown in (e), NS—not significant.
TaBle 1 | Effect of leptin treatment on femoral bone density of female adult Siberian hamsters housed in long day and short day photoperiods.
Parameter measured long day  
vehicle
long day  
leptin
short day  
vehicle
short day  
leptin
effect of  
photoperiod
effect of  
leptin
effect of photoperiod 
and leptin interaction
Bone volume (mm3) 21.27 ± 0.84 19.37 ± 2.00 22.35 ± 0.70 22.07 ± 0.96 P = 0.02 NS, P = 0.1370 NS, P = 0.2577
Bone surface (mm2) 218.1 ± 20.82 216.3 ± 7.72 228.3 ± 11.23 226.6 ± 9.50 NS, P = 0.2333 NS, P = 0.8311 NS, P = 0.9997
Bone surface/bone  
volume ratio
10.12 ± 1.03 11.06 ± 1.01 10.08 ± 0.78 10.12 ± 0.66 NS, P = 0.3562 NS, P = 0.3552 NS, P = 0.3952
Mean bone density (1/cm) 2.593 ± 0.05 2.560 ± 0.05 2.511 ± 0.09 2.559 ± 0.10 NS, P = 0.3403 NS, P = 0.8684 NS, P = 0.3526
Trabecular number (1/mm) 1.479 ± 0.74 0.9993 ± 0.47 0.9812 ± 0.75 1.686 ± 0.28 NS, P = 0.7867 NS, P = 0.7473 NS, P = 0.1157
Trabecular spacing (mm) 1.018 ± 0.94 1.403 ± 0.62 0.8327 ± 0.77 0.6067 ± 0.13 NS, P = 0.2521 NS, P = 0.8465 NS, P = 0.4650
Trabecular thickness (mm) 0.2420 ± 0.02 0.2171 ± 0.02 0.3218 ± 0.14 0.2419 ± 0.02 NS, P = 0.2113 NS, P = 0.2107 NS, P = 0.4970
Connectivity density (mm3) 1.503 ± 0.62 1.382 ± 0.33 1.361 ± 0.51 1.223 ± 0.16 NS, P = 0.5775 NS, P = 0.6292 NS, P = 0.9753
Data given as mean ± SD, n = 3 (n = 4, long day—vehicle). Two-way ANOVA with Tukey’s post hoc test, NS—not significant.
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This adds further evidence to the suggestion of central leptin 
resistance occurring in the LD-housed animals, as their insulin 
levels decreased after treatment with leptin, implying that 
peripheral mechanisms were no longer effective.
Mineral apposition rate of the Siberian hamsters was signifi-
cantly affected by leptin treatment, and interestingly, this effect 
differed depending on the photoperiod the animals were housed 
in. In agreement with the first two experiments, the MAR of SD 
animals was increased compared to LD in the vehicle animals, 
and so it was expected that leptin would have a negative effect 
on MAR in animals treated with recombinant leptin. However, 
rather than a consistent effect of leptin in animals housed in each 
photoperiod, there was an interaction effect between leptin treat-
ment and photoperiod. This resulted in MAR being lower in SD 
animals treated with leptin and higher in LD animals, compared 
to their vehicle counterparts. This study was designed to manipu-
late the serum leptin levels of SD animals to be similar to LD 
hamsters. The MAR of SD-treated animals was decreased to the 
point that it was no longer significantly different to LD animals, 
supporting an anti-osteogenic role of leptin. A role for leptin in 
bone growth and remodeling has been reported in many stud-
ies; however, the results have been conflicting. Leptin knockout 
mouse models have been the basis of a majority of the in vivo 
studies and these showed leptin to have both osteogenic (6, 39–41) 
and anti-osteogenic properties (5, 42–44). In our initial studies, 
serum leptin levels were significantly lower in the SD animals, 
and so there is was potentially an association between decreased 
serum leptin levels and increased MAR. In agreement with this, 
increased MAR has been demonstrated in leptin-deficient, ob/ob, 
mice (43, 44). However, there is also contrasting data from Bartell 
et al. (45) who showed ob/ob mice to have increased MAR only 
after leptin treatment. Taken together, the results of the present 
study are all consistent with an anti-osteogenic role of leptin.
Leptin had an opposite effect on LD-treated animals, with 
MAR being higher than the vehicle animals. Although this was 
not expected, it lends further evidence to the suggestions of leptin 
resistance occurring in LD, leptin-treated animals (23–25). Human 
obesity has also been described as a state of leptin insensitivity, as 
high levels of food intake and body adiposity occur despite very 
elevated circulating leptin concentrations. A physiological resist-
ance at the blood–brain barrier has been hypothesized as explana-
tion for this (46). It has been demonstrated that leptin uptake 
into the brain is reduced in obese mice and control mice that are 
treated with excess leptin (47). This was despite no change in the 
expression of Ob-Ra, the receptor responsible for blood–brain 
barrier transport of leptin (48), indicating a mechanistic change 
that is yet to be defined. In agreement with this, the body weight 
reducing action of leptin has been demonstrated in obese rodents 
if treated centrally, but not peripherally (49). We also found serum 
insulin levels to be decreased in leptin-treated animals in LD, 
which may well reflect leptin modulating glucose homeostasis 
via central mechanisms (38), consistent with the idea that leptin 
could also act via a centrally mediated mechanism to negatively 
regulate appositional bone growth in our animal model.
We have reported femoral growth plate size measurements in 
Siberian hamsters for the first time and have shown that there 
is an effect of photoperiod. SD-housed animals had increased 
total growth plate width, and this was seen in both the prolifera-
tive and hypertrophic zones, consistent with the increased bone 
growth rates seen using MAR. In addition, this study found that 
the growth plate widths were not affected by leptin treatment. 
This is in contrast to several studies which found growth plate 
length to be increased after leptin treatment (39, 50, 51), and 
the long bones of ob/ob mice to be shorter (6, 39–41). Bone 
density measurements agreed with our initial studies, showing 
no measurable effect of photoperiod, or leptin, consistent with 
previously published observations (23).
A limitation of the current study was that the leptin delivered 
via the pump ceased prior to the study ending. In previous 
studies, animals were treated for 14 days before euthanasia using 
sequential implantation of two osmotic mini-pumps that were 
changed after 7 days (23, 24). In the present study, the hamsters 
received a single 28-day osmotic mini-pump to minimize surgi-
cal stress to the animals, but blood samples and tissues were not 
collected until day 31 after the implantation of mini-pumps. This 
is likely to have resulted in the observation that leptin levels were 
not significantly different between leptin and vehicle treatment 
groups within each photoperiod, as leptin has a half-life of less 
than an hour in rodents (52), so levels would rapidly revert to 
normal after supplementation ends (53). Unfortunately, it was 
not possible to measure leptin longitudinally due to the small 
blood volume of a Siberian hamster and difficulties in obtaining 
samples (no accessible tail vein). While it is recognized that the 
body weight changes and serum leptin levels at the end of the 
study are not as expected, there is evidence to show that bone 
changes due to leptin are apparent at much lower levels than 
those needed for changes in body weight (54). In addition, the l/l 
mouse model, which has increased leptin signaling, is osteoporo-
tic despite no changes in food intake or reproductive function, 
suggesting that a smaller change in leptin signaling is required to 
affect bone compared to its other functions (55).
In conclusion, we have demonstrated for the first time that 
photoperiod has a reproducible and significant effect on bone 
growth parameters including both MAR and growth plate size at 
several time points and in both sexes. No changes were observed 
in measures of bone mass, consistent with the only previous 
study examining these parameters (23). While inconclusive, we 
observed some findings of interest that warrant further study. 
First, with leptin treatment the MAR of SD animals reduced and 
began to approach those of LD animals to the point where they 
was no longer a statistically significant difference between them, 
implying that leptin has a catabolic effect on bone growth. Second, 
the effects of leptin treatment were photoperiod-dependent, 
lacking the usual significant reduction in MAR observed in 
leptin-treated hamsters in LD. This supports the hypothesis that 
supplementing leptin in an existing state of adiposity can promote 
leptin resistance (probably centrally mediated, supported by the 
insulin findings), and further implies an anti-osteogenic role for 
leptin in bone.
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